Maternofoetal Complications and Their Association with Proteinuria in a Tertiary Care Hospital of a Developing Country

Overview

Journal J Pregnancy

Publisher Wiley

Specialty Gynecology & Obstetrics

Date 2014 May 16

PMID 24829801

Citations 4

Authors

Archana Kumari

Avinash Chakrawarty

Abha Singh

Ritu Singh

Affiliations

Soon will be listed here.

Abstract

OBJECTIVE. To investigate association between maternofoetal complications and the amount of proteinuria measured by spot urine protein creatinine ratio in patients with preeclampsia. METHODS. 200 consecutive patients with preeclampsia were recruited in the study. The complications like first episode of severe hypertension, renal insufficiency, raised level of aspartate transaminase, signs of neurological involvement, thrombocytopenia, eclampsia, and need to shift in intensive care units were studied. The maternal outcome was studied in terms of type of labour, outcome of pregnancy, mode of delivery, indication of cesarean section, and maternal mortality. The foetal complications and outcome parameters were birth weight, Apgar score at the time of birth and at five minutes, need of high dependency unit care, and perinatal mortality. RESULT. The frequency of various maternal and foetal complications was between 14-53% and 22-92%, respectively. Maternal mortality was 3%, whereas perinatal mortality was 23%. Statistically significant association was found between the frequencies of various complications in mother and newborn and spot UPCR. CONCLUSION. The rate of various maternofoetal complications in preeclampsia is higher in developing countries than in developed world. Maternofoetal complications and outcome correlate with maternal spot UPCR.

Citing Articles

Proteinuria among Pregnant Women Admitted to the Department of Obstetrics and Gynaecology of a Tertiary Care Centre.

Ghimire A, Koirala P, Rijal H, Chamlagain A, Pant P JNMA J Nepal Med Assoc. 2024; 62(269):9-12.

PMID: 38410018 PMC: 10924488. DOI: 10.31729/jnma.8388.

Urinary Protein-to-Creatinine Ratio: An Indicator of Adverse Clinical Outcomes in Preeclampsia With Proteinuria.

Chadha A, Tayade S Cureus. 2022; 14(3):e23341.

PMID: 35464597 PMC: 9017718. DOI: 10.7759/cureus.23341.

Proteinuria may be an indicator of adverse pregnancy outcomes in patients with preeclampsia: a retrospective study.

Lei T, Qiu T, Liao W, Li K, Lai X, Huang H Reprod Biol Endocrinol. 2021; 19(1):71.

PMID: 33990220 PMC: 8120921. DOI: 10.1186/s12958-021-00751-y.

Massive Urinary Protein Excretion Associated with Greater Neonatal Risk in Preeclampsia.

Mateus J, Newman R, Sibai B, Li Q, Barton J, Combs C AJP Rep. 2017; 7(1):e49-e58.

PMID: 28348923 PMC: 5365400. DOI: 10.1055/s-0037-1601866.

References

Thangaratinam S, Ismail K, Sharp S, Coomarasamy A, Khan K . Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review. BJOG. 2006; 113(4):369-78. DOI: 10.1111/j.1471-0528.2006.00908.x. View

Bhattacharya S, Campbell D . The incidence of severe complications of preeclampsia. Hypertens Pregnancy. 2005; 24(2):181-90. DOI: 10.1081/PRG-200059873. View

Liu C, Cheng P, Chang S . Maternal complications and perinatal outcomes associated with gestational hypertension and severe preeclampsia in Taiwanese women. J Formos Med Assoc. 2008; 107(2):129-38. DOI: 10.1016/S0929-6646(08)60126-6. View

Bramham K, Poli-de-Figueiredo C, Seed P, Briley A, Poston L, Shennan A . Association of proteinuria threshold in pre-eclampsia with maternal and perinatal outcomes: a nested case control cohort of high risk women. PLoS One. 2013; 8(10):e76083. PMC: 3794944. DOI: 10.1371/journal.pone.0076083. View

Morris R, Riley R, Doug M, Deeks J, Kilby M . Diagnostic accuracy of spot urinary protein and albumin to creatinine ratios for detection of significant proteinuria or adverse pregnancy outcome in patients with suspected pre-eclampsia: systematic review and meta-analysis. BMJ. 2012; 345:e4342. PMC: 3392077. DOI: 10.1136/bmj.e4342. View

Caritis S, Sibai B, Hauth J, Lindheimer M, VanDorsten P, Klebanoff M . Predictors of pre-eclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol. 1998; 179(4):946-51. DOI: 10.1016/s0002-9378(98)70194-2. View

Yucesoy G, Ozkan S, Bodur H, Tan T, Caliskan E, Vural B . Maternal and perinatal outcome in pregnancies complicated with hypertensive disorder of pregnancy: a seven year experience of a tertiary care center. Arch Gynecol Obstet. 2005; 273(1):43-9. DOI: 10.1007/s00404-005-0741-3. View

Sibiude J, Guibourdenche J, Dionne M, LE Ray C, Anselem O, Serreau R . Placental growth factor for the prediction of adverse outcomes in patients with suspected preeclampsia or intrauterine growth restriction. PLoS One. 2012; 7(11):e50208. PMC: 3509137. DOI: 10.1371/journal.pone.0050208. View

Tzur T, Sheiner E . Is there an association between platelet count during the first trimester and preeclampsia or other obstetric complications later in pregnancy?. Hypertens Pregnancy. 2013; 32(1):74-82. DOI: 10.3109/10641955.2012.704109. View

10.

Odegard R, Vatten L, Nilsen S, Salvesen K, Austgulen R . Risk factors and clinical manifestations of pre-eclampsia. BJOG. 2000; 107(11):1410-6. DOI: 10.1111/j.1471-0528.2000.tb11657.x. View

11.

Gangaram R, Naicker M, Moodley J . Accuracy of the spot urinary microalbumin:creatinine ratio and visual dipsticks in hypertensive pregnant women. Eur J Obstet Gynecol Reprod Biol. 2009; 144(2):146-8. DOI: 10.1016/j.ejogrb.2009.03.010. View

12.

Osungbade K, Ige O . Public health perspectives of preeclampsia in developing countries: implication for health system strengthening. J Pregnancy. 2011; 2011:481095. PMC: 3087154. DOI: 10.1155/2011/481095. View

13.

Thornton C, Makris A, Ogle R, Tooher J, Hennessy A . Role of proteinuria in defining pre-eclampsia: clinical outcomes for women and babies. Clin Exp Pharmacol Physiol. 2009; 37(4):466-70. DOI: 10.1111/j.1440-1681.2009.05334.x. View

14.

von Dadelszen P, Payne B, Li J, Ansermino J, Broughton Pipkin F, Cote A . Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet. 2010; 377(9761):219-27. DOI: 10.1016/S0140-6736(10)61351-7. View

15.

Buhimschi I, Zhao G, Funai E, Harris N, Sasson I, Bernstein I . Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia. Am J Obstet Gynecol. 2008; 199(5):551.e1-16. PMC: 2679897. DOI: 10.1016/j.ajog.2008.07.006. View

16.

Brown M, Buddle M . Hypertension in pregnancy: maternal and fetal outcomes according to laboratory and clinical features. Med J Aust. 1996; 165(7):360-5. DOI: 10.5694/j.1326-5377.1996.tb125017.x. View

17.

Thangaratinam S, Coomarasamy A, OMahony F, Sharp S, Zamora J, Khan K . Estimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review. BMC Med. 2009; 7:10. PMC: 2670320. DOI: 10.1186/1741-7015-7-10. View

18.

Srp B, Velebil P, Kvasnicka J . [Fatal complications in pre-eclampsia and eclampsia]. Ceska Gynekol. 2003; 67(6):365-71. View

19.

Chan P, Brown M, Simpson J, Davis G . Proteinuria in pre-eclampsia: how much matters?. BJOG. 2005; 112(3):280-5. DOI: 10.1111/j.1471-0528.2004.00395.x. View

20.

Carty D, Siwy J, Brennand J, Zurbig P, Mullen W, Franke J . Urinary proteomics for prediction of preeclampsia. Hypertension. 2011; 57(3):561-9. DOI: 10.1161/HYPERTENSIONAHA.110.164285. View